NCT04797130 is a NA clinical trial of Hospital Fit 2.0 in Telemedicine, sponsored by Maastricht University Medical Center.

Who is sponsoring NCT04797130?

NCT04797130 is sponsored by Maastricht University Medical Center.

What drugs are being tested in NCT04797130?

Interventions in NCT04797130: Hospital Fit 2.0.

What condition does NCT04797130 study?

NCT04797130 studies Telemedicine, Internal Medicine, Pulmonary Disease.

Is NCT04797130 still recruiting?

NCT04797130 is currently completed. Last updated 14 September 2022.

Last reviewed 2022-09-14 · How we verify

NCT04797130

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Hospital Fit 2.0 on Patients Physical Activity

Completed NA Last updated 14 September 2022

What this trial tests

NA trial testing Hospital Fit 2.0 in Telemedicine in 78 participants. Completed in 27 January 2022.

Timeline

23 March 2021

Primary endpoint
27 January 2022

27 January 2022

Quick facts

Lead sponsor	Maastricht University Medical Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	78
Start date	23 March 2021
Primary completion	27 January 2022
Estimated completion	27 January 2022
Sites	1 location across Netherlands

Drugs / interventions tested

Hospital Fit 2.0

Conditions studied

Telemedicine — all drugs for Telemedicine →
Internal Medicine — all drugs for Internal Medicine →
Pulmonary Disease — all drugs for Pulmonary Disease →

Sponsor

Maastricht University Medical Center

Who can join

Adults 18 to 75, any sex, with Telemedicine or Internal Medicine. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective of this study is to investigate if using Hospital Fit 2.0 as part of the usual care physiotherapy treatment of patients hospitalised at the department of Internal Medicine and the department of Pulmonology in MUMC+ will result in an increase in the amount of PA performed compared to patients who do not use Hospital Fit 2.0 as part of the physiotherapy treatment.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The Effect of a Smartphone App with an Accelerometer on the Physical Activity Behavior of Hospitalized Patients: A Randomized Controlled Trial.
Dijk-Huisman HCV, Senden R, Smeets MHH, Marcellis RGJ, et al · · 2023 · cited 6× · PMID 37960404 · DOI 10.3390/s23218704

Verify or expand the search:

Other recruiting trials for Telemedicine

Currently open trials in the same condition.

NCT07265037 — Integrated TCM - Western Medicine Strategy for Long - Distance Diabetes Management · NA · recruiting
NCT07042477 — Integrated Telemedicine Program Evaluation · NA · recruiting
NCT07124325 — Remote Cardiotocography Telemonitoring Within High-risk Pregnancy Care · NA · recruiting
NCT06942533 — Effect of Visual Feedback From the SpiroGym Mobile Application · NA · recruiting
NCT06980740 — Video-Tumorboard PLUS · recruiting

Other Maastricht University Medical Center trials

Trials by the same sponsor.

NCT04603261 — Time to Excretion of Contrast, a Maastricht Prospective Observational Study · withdrawn
NCT04598516 — Maastricht Investigation of Renal Function in Absence of- and Post- Contrast in Patients With eGFR LEss Than 30 · withdrawn
NCT04597892 — Efficacy of Point-Of-Care Creatinine Assays in Patients With eGFR <30 Receiving Intravascular Contrast · withdrawn
NCT07287358 — Optimal Cerebral Perfusion Pressure Guided Therapy: Assessment of Target Effectiveness - II · NA · not yet recruiting
NCT07501780 — Real-world Evaluation of the Implementation of LC-OCT in Daily Clinical Practice · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04797130 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Maastricht University Medical Center
Last refreshed: 14 September 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04797130.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing